Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Dec 7, 2022--
The "Alpha Emitters: Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Alpha Emitters estimated at US$684.5 Million in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2027, growing at a CAGR of 20.6% over the analysis period 2020-2027.
Bone Metastasis, one of the segments analyzed in the report, is projected to record a 20.1% CAGR and reach US$888.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Ovarian Cancer segment is readjusted to a revised 21.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $203.1 Million, While China is Forecast to Grow at 19.9% CAGR
The Alpha Emitters market in the U.S. is estimated at US$203.1 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$437.5 Million by the year 2027 trailing a CAGR of 19.9% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.4% and 17.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.3% CAGR.
Pancreatic Cancer Segment to Record 21.2% CAGR
In the global Pancreatic Cancer segment, USA, Canada, Japan, China and Europe will drive the 21.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$94.5 Million in the year 2020 will reach a projected size of US$357.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
Select Competitors (Total 12 Featured) -
What's New for 2022?
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/sjgsx1
View source version on businesswire.com:https://www.businesswire.com/news/home/20221207005424/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 12/07/2022 05:02 AM/DISC: 12/07/2022 05:02 AM
http://www.businesswire.com/news/home/20221207005424/en